HEALEY ALS Platform Trial - Regimen I NUZ-001
HEALEY ALS Platform Trial - Regimen I NUZ-001
Active, not recruiting · NCT07410806 · Registry updated 2026-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HEALEY ALS Platform Trial - Regimen I NUZ-001 | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-07-20 | NCT07410806 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merit E. Cudkowicz, MD | 2 |
| Neurizon Therapeutics Limited | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Healey Center for ALS at Massachusetts General Hospital | Boston | United States | 1 |